DE60210960D1 - Carbamat-verbindungen zur prävention oder behandlung von angstzuständen - Google Patents

Carbamat-verbindungen zur prävention oder behandlung von angstzuständen

Info

Publication number
DE60210960D1
DE60210960D1 DE60210960T DE60210960T DE60210960D1 DE 60210960 D1 DE60210960 D1 DE 60210960D1 DE 60210960 T DE60210960 T DE 60210960T DE 60210960 T DE60210960 T DE 60210960T DE 60210960 D1 DE60210960 D1 DE 60210960D1
Authority
DE
Germany
Prior art keywords
group
phenyl
alkyl
difficulties
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60210960T
Other languages
English (en)
Other versions
DE60210960T2 (de
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of DE60210960D1 publication Critical patent/DE60210960D1/de
Application granted granted Critical
Publication of DE60210960T2 publication Critical patent/DE60210960T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60210960T 2001-02-27 2002-02-21 Carbamat-verbindungen zur prävention oder behandlung von angstzuständen Expired - Lifetime DE60210960T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27168901P 2001-02-27 2001-02-27
US271689P 2001-02-27
PCT/US2002/005423 WO2002067923A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating anxiety disorders

Publications (2)

Publication Number Publication Date
DE60210960D1 true DE60210960D1 (de) 2006-06-01
DE60210960T2 DE60210960T2 (de) 2006-11-16

Family

ID=23036639

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60210960T Expired - Lifetime DE60210960T2 (de) 2001-02-27 2002-02-21 Carbamat-verbindungen zur prävention oder behandlung von angstzuständen

Country Status (26)

Country Link
US (3) US7078436B2 (de)
EP (1) EP1399144B1 (de)
JP (1) JP2004523554A (de)
KR (1) KR20030078947A (de)
CN (1) CN1503665A (de)
AT (1) ATE324107T1 (de)
AU (1) AU2002306567B2 (de)
BR (1) BR0207830A (de)
CA (1) CA2439286A1 (de)
CY (1) CY1107468T1 (de)
CZ (1) CZ20032311A3 (de)
DE (1) DE60210960T2 (de)
DK (1) DK1399144T3 (de)
ES (1) ES2262826T3 (de)
HK (1) HK1062270A1 (de)
HU (1) HUP0303262A2 (de)
IL (1) IL157594A0 (de)
MX (1) MXPA03007720A (de)
MY (1) MY136391A (de)
NO (1) NO20033800L (de)
NZ (1) NZ546549A (de)
PL (1) PL364639A1 (de)
PT (1) PT1399144E (de)
RS (1) RS50505B (de)
RU (1) RU2292881C2 (de)
WO (1) WO2002067923A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS50505B (sr) * 2001-02-27 2010-03-02 Ortho-Mcneil Pharmaceutical Inc. Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju anksioznih poremećaja
EA200701536A1 (ru) * 2005-01-20 2008-02-28 Янссен Фармацевтика, Н.В. Способы контроля интервала qt
WO2006133393A1 (en) 2005-06-08 2006-12-14 Sk Holdings Co., Ltd. Treatment of sleep-wake disorders
ATE489083T1 (de) * 2006-10-27 2010-12-15 Janssen Pharmaceutica Nv Verfahren zur behandlung disruptiver verhaltensstörungen
US8263652B2 (en) 2007-10-31 2012-09-11 Sk Biopharmaceuticals Co., Ltd. Stabilized pediatric suspension of carisbamate
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
KR101717872B1 (ko) 2013-03-12 2017-03-17 (주)바이오팜솔루션즈 소아 간질 및 간질-관련 증후군의 예방 또는 치료용 페닐카바메이트 화합물
KR101758543B1 (ko) * 2013-03-12 2017-07-14 (주)바이오팜솔루션즈 페닐카바메이트 화합물 및 이를 포함하는 신경가스에 의한 질환의 예방 또는 치료용 조성물
CA3016253C (en) * 2016-02-29 2020-12-29 Bio-Pharm Solutions Co., Ltd. Sulfamate derivative compounds, processes for preparing them and their uses
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
KR20200016889A (ko) 2017-06-02 2020-02-17 재즈 파마슈티칼즈 아일랜드 리미티드 과다 졸림증을 치료하기 위한 방법 및 조성물
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3248418A (en) * 1962-06-26 1966-04-26 Charles D Bossinger 2-hydroxy-2-phenyl alkyl carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
IL157588A0 (en) 2001-02-27 2004-03-28 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating psychotic disorders
DK1408953T3 (da) 2001-02-27 2006-08-21 Ortho Mcneil Pharm Inc Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom
RS50505B (sr) * 2001-02-27 2010-03-02 Ortho-Mcneil Pharmaceutical Inc. Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju anksioznih poremećaja

Also Published As

Publication number Publication date
US20090234003A1 (en) 2009-09-17
CN1503665A (zh) 2004-06-09
US20020143053A1 (en) 2002-10-03
CY1107468T1 (el) 2012-12-19
KR20030078947A (ko) 2003-10-08
US20050267203A1 (en) 2005-12-01
EP1399144A1 (de) 2004-03-24
EP1399144B1 (de) 2006-04-26
NZ546549A (en) 2007-11-30
AU2002306567B2 (en) 2006-08-17
PT1399144E (pt) 2006-07-31
YU67903A (sh) 2006-08-17
WO2002067923A1 (en) 2002-09-06
HUP0303262A2 (hu) 2004-01-28
DK1399144T3 (da) 2006-07-24
ATE324107T1 (de) 2006-05-15
BR0207830A (pt) 2004-06-22
CA2439286A1 (en) 2002-09-06
ES2262826T3 (es) 2006-12-01
DE60210960T2 (de) 2006-11-16
IL157594A0 (en) 2004-03-28
CZ20032311A3 (cs) 2005-02-16
MXPA03007720A (es) 2004-11-12
RU2292881C2 (ru) 2007-02-10
US7078436B2 (en) 2006-07-18
NO20033800L (no) 2003-09-26
HK1062270A1 (en) 2004-10-29
MY136391A (en) 2008-09-30
NO20033800D0 (no) 2003-08-26
PL364639A1 (en) 2004-12-13
JP2004523554A (ja) 2004-08-05
RU2003128986A (ru) 2005-03-20
RS50505B (sr) 2010-03-02

Similar Documents

Publication Publication Date Title
DE602005020667D1 (de) Verwendung von 2-phenyl-1,2-ethanediol-(di)carbamaten zur behandlung von epileptogenese
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
YU67703A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
DE60210976D1 (de) Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung
DE60223506D1 (de) Carbamatverbindungen zur vorbeugung oder behandlung bipolarer erkrankungen
DE60210960D1 (de) Carbamat-verbindungen zur prävention oder behandlung von angstzuständen
RS67603A (en) Carbamate compounds for use in the treatment of pain
RS67503A (en) Carbamate compounds for use in preventing of treating psychotic disorders
PT1305082E (pt) Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca
ATE435014T1 (de) Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Legal Events

Date Code Title Description
8364 No opposition during term of opposition